 | • レポートコード：MRC23Q35985 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の好酸球性喘息治療薬市場について調査・分析し、世界の好酸球性喘息治療薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（静脈内注射、皮下注射）、用途別セグメント分析（子供、大人、青少年）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、AstraZeneca、GSK、Genentech (Roche Group) & Novartis、Regeneron Pharmaceuticals & Sanofi、Teva Pharmaceuticalsなどが含まれています。世界の好酸球性喘息治療薬市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、好酸球性喘息治療薬市場規模を推定する際に考慮しました。本レポートは、好酸球性喘息治療薬の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、好酸球性喘息治療薬に関するビジネス上の意思決定に役立てることを目的としています。 ・好酸球性喘息治療薬市場の概要 - 好酸球性喘息治療薬のタイプ別セグメント - 世界の好酸球性喘息治療薬市場規模：タイプ別分析（静脈内注射、皮下注射） - 好酸球性喘息治療薬の用途別セグメント - 世界の好酸球性喘息治療薬市場規模：用途別分析（子供、大人、青少年） - 世界の好酸球性喘息治療薬市場規模予測（2018年-2029年） ・好酸球性喘息治療薬市場の成長トレンド - 好酸球性喘息治療薬の地域別市場規模（2018年-2029年） - 好酸球性喘息治療薬市場ダイナミクス - 好酸球性喘息治療薬の業界動向 - 好酸球性喘息治療薬市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：静脈内注射、皮下注射 - 世界の好酸球性喘息治療薬のタイプ別市場規模（2018年-2023年） - 世界の好酸球性喘息治療薬のタイプ別市場規模（2024年-2029年） ・用途別セグメント：子供、大人、青少年 - 世界の好酸球性喘息治療薬の用途別市場規模（2018年-2023年） - 世界の好酸球性喘息治療薬の用途別市場規模（2024年-2029年） ・好酸球性喘息治療薬の地域別市場規模 - 北米の好酸球性喘息治療薬市場規模（2018年-2029年） - アメリカの好酸球性喘息治療薬市場規模（2018年-2029年） - ヨーロッパの好酸球性喘息治療薬市場規模（2018年-2029年） - アジア太平洋の好酸球性喘息治療薬市場規模（2018年-2029年） - 中国の好酸球性喘息治療薬市場規模（2018年-2029年） - 日本の好酸球性喘息治療薬市場規模（2018年-2029年） - 韓国の好酸球性喘息治療薬市場規模（2018年-2029年） - インドの好酸球性喘息治療薬市場規模（2018年-2029年） - オーストラリアの好酸球性喘息治療薬市場規模（2018年-2029年） - 中南米の好酸球性喘息治療薬市場規模（2018年-2029年） - 中東・アフリカの好酸球性喘息治療薬市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 AstraZeneca、GSK、Genentech (Roche Group) & Novartis、Regeneron Pharmaceuticals & Sanofi、Teva Pharmaceuticals ・アナリストの観点/結論 ・調査方法とデータソース |
Eosinophilic asthma (EA) is a type of severe asthma. It’s marked by high levels of white blood cells. This report mianly studies Eosinophilic Asthma Treatment market.
Highlights
The global Eosinophilic Asthma Treatment market was valued at US$ 19100 million in 2022 and is anticipated to reach US$ 136480 million by 2029, witnessing a CAGR of 38.8% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key Eosinophilic Asthma treatment brands include Regeneron Pharmaceuticals & Sanofi, Genentech (Roche Group) & Novartis and GSK etc. The top 3 companies hold a share about 88%. North America is the largset market with a share about 40%, followed by Europe and Asia-Pacific.
In terms of treatment, subcutaneous injection is the largest segment with a share of 95%. And in terms of end users, adult is the largest end user with a share about 55%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Eosinophilic Asthma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eosinophilic Asthma Treatment.
The Eosinophilic Asthma Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Eosinophilic Asthma Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eosinophilic Asthma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
AstraZeneca
GSK
Genentech (Roche Group) & Novartis
Regeneron Pharmaceuticals & Sanofi
Teva Pharmaceuticals
Segment by Type
Intravenous Infusion
Subcutaneous Injection
Segment by Application
Children
Adults
Teenagers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Eosinophilic Asthma Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Eosinophilic Asthma Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Intravenous Infusion
1.2.3 Subcutaneous Injection
1.3 Market by Application
1.3.1 Global Eosinophilic Asthma Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Children
1.3.3 Adults
1.3.4 Teenagers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Eosinophilic Asthma Treatment Market Perspective (2018-2029)
2.2 Eosinophilic Asthma Treatment Growth Trends by Region
2.2.1 Global Eosinophilic Asthma Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Eosinophilic Asthma Treatment Historic Market Size by Region (2018-2023)
2.2.3 Eosinophilic Asthma Treatment Forecasted Market Size by Region (2024-2029)
2.3 Eosinophilic Asthma Treatment Market Dynamics
2.3.1 Eosinophilic Asthma Treatment Industry Trends
2.3.2 Eosinophilic Asthma Treatment Market Drivers
2.3.3 Eosinophilic Asthma Treatment Market Challenges
2.3.4 Eosinophilic Asthma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Eosinophilic Asthma Treatment Players by Revenue
3.1.1 Global Top Eosinophilic Asthma Treatment Players by Revenue (2018-2023)
3.1.2 Global Eosinophilic Asthma Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Eosinophilic Asthma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Eosinophilic Asthma Treatment Revenue
3.4 Global Eosinophilic Asthma Treatment Market Concentration Ratio
3.4.1 Global Eosinophilic Asthma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Eosinophilic Asthma Treatment Revenue in 2022
3.5 Eosinophilic Asthma Treatment Key Players Head office and Area Served
3.6 Key Players Eosinophilic Asthma Treatment Product Solution and Service
3.7 Date of Enter into Eosinophilic Asthma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Eosinophilic Asthma Treatment Breakdown Data by Type
4.1 Global Eosinophilic Asthma Treatment Historic Market Size by Type (2018-2023)
4.2 Global Eosinophilic Asthma Treatment Forecasted Market Size by Type (2024-2029)
5 Eosinophilic Asthma Treatment Breakdown Data by Application
5.1 Global Eosinophilic Asthma Treatment Historic Market Size by Application (2018-2023)
5.2 Global Eosinophilic Asthma Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Eosinophilic Asthma Treatment Market Size (2018-2029)
6.2 North America Eosinophilic Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Eosinophilic Asthma Treatment Market Size by Country (2018-2023)
6.4 North America Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Eosinophilic Asthma Treatment Market Size (2018-2029)
7.2 Europe Eosinophilic Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Eosinophilic Asthma Treatment Market Size by Country (2018-2023)
7.4 Europe Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Eosinophilic Asthma Treatment Market Size (2018-2029)
8.2 Asia-Pacific Eosinophilic Asthma Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Eosinophilic Asthma Treatment Market Size (2018-2029)
9.2 Latin America Eosinophilic Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Eosinophilic Asthma Treatment Market Size by Country (2018-2023)
9.4 Latin America Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Eosinophilic Asthma Treatment Market Size (2018-2029)
10.2 Middle East & Africa Eosinophilic Asthma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Eosinophilic Asthma Treatment Introduction
11.1.4 AstraZeneca Revenue in Eosinophilic Asthma Treatment Business (2018-2023)
11.1.5 AstraZeneca Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Eosinophilic Asthma Treatment Introduction
11.2.4 GSK Revenue in Eosinophilic Asthma Treatment Business (2018-2023)
11.2.5 GSK Recent Development
11.3 Genentech (Roche Group) & Novartis
11.3.1 Genentech (Roche Group) & Novartis Company Detail
11.3.2 Genentech (Roche Group) & Novartis Business Overview
11.3.3 Genentech (Roche Group) & Novartis Eosinophilic Asthma Treatment Introduction
11.3.4 Genentech (Roche Group) & Novartis Revenue in Eosinophilic Asthma Treatment Business (2018-2023)
11.3.5 Genentech (Roche Group) & Novartis Recent Development
11.4 Regeneron Pharmaceuticals & Sanofi
11.4.1 Regeneron Pharmaceuticals & Sanofi Company Detail
11.4.2 Regeneron Pharmaceuticals & Sanofi Business Overview
11.4.3 Regeneron Pharmaceuticals & Sanofi Eosinophilic Asthma Treatment Introduction
11.4.4 Regeneron Pharmaceuticals & Sanofi Revenue in Eosinophilic Asthma Treatment Business (2018-2023)
11.4.5 Regeneron Pharmaceuticals & Sanofi Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Detail
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Eosinophilic Asthma Treatment Introduction
11.5.4 Teva Pharmaceuticals Revenue in Eosinophilic Asthma Treatment Business (2018-2023)
11.5.5 Teva Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details